(VIANEWS) – Invesco Trust for Investment Grade New York Municipals (VTN), Fomento Economico Mexicano S.A.B. de C.V. (FMX), Peoples Bancorp (PEBO) are the highest payout ratio stocks on this list.
Here’s the data we’ve collected of stocks with a high payout ratio up to now. The payout ratio in itself isn’t a promise of a future good investment but it’s an indicator of whether dividends are being paid and how the company chooses to issue them.
When researching a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.
1. Invesco Trust for Investment Grade New York Municipals (VTN)
264.38% Payout Ratio
Invesco Trust for Investment Grade New York Municipals is a closed-ended fixed income mutual fund launched by Invesco Ltd. The fund is co-managed by Invesco Advisers, Inc., INVESCO Asset Management (Japan) Limited, INVESCO Asset Management Deutschland GmbH, INVESCO Asset Management Limited, Invesco Canada Ltd., Invesco Hong Kong Limited, and INVESCO Senior Secured Management, Inc. It invests in the fixed income markets of the United States. The fund primarily invests in investment grade New York municipal securities which include municipal bonds, municipal notes, municipal commercial paper, and lease obligations. It employs fundamental analysis with bottom-up security selection approach to create its portfolio. The fund was formerly known as Invesco Van Kampen Trust for Investment Grade New York Municipals. Invesco Trust for Investment Grade New York Municipals was formed on March 27, 1992 and is domiciled in the United States.
Earnings Per Share
As for profitability, Invesco Trust for Investment Grade New York Municipals has a trailing twelve months EPS of $0.16.
PE Ratio
Invesco Trust for Investment Grade New York Municipals has a trailing twelve months price to earnings ratio of 67.06. Meaning, the purchaser of the share is investing $67.06 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1.41%.
Volume
Today’s last reported volume for Invesco Trust for Investment Grade New York Municipals is 41520 which is 2.54% below its average volume of 42605.
Moving Average
Invesco Trust for Investment Grade New York Municipals’s worth is above its 50-day moving average of $10.54 and above its 200-day moving average of $9.97.
Revenue Growth
Year-on-year quarterly revenue growth grew by 5.1%, now sitting on 15.18M for the twelve trailing months.
2. Fomento Economico Mexicano S.A.B. de C.V. (FMX)
195.85% Payout Ratio
Fomento Económico Mexicano, S.A.B. de C.V., through its subsidiaries, operates as a bottler of Coca-Cola trademark beverages. The company produces, markets, and distributes Coca-Cola trademark beverages in Mexico, Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil, Argentina, and Uruguay. It also operates small-box retail chain stores in Mexico, Colombia, Peru, Chile, and Brazil under the OXXO name; retail service stations for fuels, motor oils, lubricants, and car care products under the OXXO GAS name in Mexico; and drugstores in Chile, Colombia, Ecuador, and Mexico under the Cruz Verde, Fybeca, SanaSana, YZA, La Moderna, and Farmacon names. In addition, the company is involved in the production and distribution of collers, commercial refrigeration equipment, plastic boxes, food processing, and preservation and weighing equipment; and provision of logistic transportation, distribution and maintenance, point-of-sale refrigeration, and plastics solutions, as well as distribution platform for cleaning products and consumables. Further, it operates small-box retail and food convenience chain stores in Switzerland, Germany, Austria, Luxembourg, and the Netherlands under the k kiosk, Brezelkönig, BackWerk, Ditsch, Press & Books, avec, Caffè Spettacolo, and ok.–) names, as well as pretzels under the Ditsch name. The company was founded in 1890 and is based in Monterrey, Mexico.
Earnings Per Share
As for profitability, Fomento Economico Mexicano S.A.B. de C.V. has a trailing twelve months EPS of $1.15.
PE Ratio
Fomento Economico Mexicano S.A.B. de C.V. has a trailing twelve months price to earnings ratio of 113.28. Meaning, the purchaser of the share is investing $113.28 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.59%.
Moving Average
Fomento Economico Mexicano S.A.B. de C.V.’s worth is below its 50-day moving average of $131.48 and way above its 200-day moving average of $117.61.
Sales Growth
Fomento Economico Mexicano S.A.B. de C.V.’s sales growth is 14.1% for the current quarter and 11.4% for the next.
Yearly Top and Bottom Value
Fomento Economico Mexicano S.A.B. de C.V.’s stock is valued at $130.27 at 20:23 EST, below its 52-week high of $143.43 and way above its 52-week low of $85.66.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 136.8% and a drop 39% for the next.
3. Peoples Bancorp (PEBO)
45.06% Payout Ratio
Peoples Bancorp Inc. operates as the holding company for Peoples Bank that provides commercial and retail banking products and services. The company accepts various deposit products, including demand deposit accounts, savings accounts, money market accounts, and certificates of deposit; and provides commercial and industrial, commercial real estate, construction, finance, residential real estate, and consumer indirect and direct loans, as well as home equity lines of credit and overdrafts. It also offers debit and automated teller machine (ATM) cards; safe deposit rental facilities; money orders and cashier's checks; and telephone, mobile, and Internet-based banking services. In addition, the company provides various life, health, and property and casualty insurance products; third-party insurance administration; insurance premium financing; commercial and technology equipment leasing; fiduciary and trust; underwriting, origination and servicing of equipment leases, and equipment financing agreements; and asset management and administration services, as well as employee benefit, retirement, and health care plan administration services. Further, it offers brokerage services through an unaffiliated registered broker-dealers; insurance premium finance lending and lease financing services; and credit cards to individuals and businesses, as well as provides merchant credit card transaction processing, and person-to-person payment processing services. The company operates through 135 financial service offices and ATMs, including 119 full-service branches in Ohio, West Virginia, Kentucky, Virginia, Washington, D.C., and Maryland. Peoples Bancorp Inc. was founded in 1902 and is based in Marietta, Ohio.
Earnings Per Share
As for profitability, Peoples Bancorp has a trailing twelve months EPS of $3.44.
PE Ratio
Peoples Bancorp has a trailing twelve months price to earnings ratio of 8.18. Meaning, the purchaser of the share is investing $8.18 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.33%.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 15.6% and positive 29.7% for the next.
Volume
Today’s last reported volume for Peoples Bancorp is 66503 which is 47.65% below its average volume of 127049.
Yearly Top and Bottom Value
Peoples Bancorp’s stock is valued at $28.14 at 20:23 EST, way under its 52-week high of $34.85 and way higher than its 52-week low of $23.05.
4. ResMed (RMD)
30.46% Payout Ratio
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, ResMed has a trailing twelve months EPS of $6.05.
PE Ratio
ResMed has a trailing twelve months price to earnings ratio of 32.73. Meaning, the purchaser of the share is investing $32.73 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.66%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
ResMed’s EBITDA is 6.42.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.5%, now sitting on 4.5B for the twelve trailing months.
Moving Average
ResMed’s value is way above its 50-day moving average of $179.87 and way higher than its 200-day moving average of $176.98.
1. 1 (1)
1% Payout Ratio
1
Earnings Per Share
As for profitability, 1 has a trailing twelve months EPS of $1.
PE Ratio
1 has a trailing twelve months price to earnings ratio of 1. Meaning, the purchaser of the share is investing $1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 1%.
